Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Genome Biologics
Genome Biologics is a biotechnology company specializing in therapeutic target and drug discovery for cardiovascular and cardiometabolic diseases. Their business model focuses on developing…
Genome Biologics
Genome Biologics is a biotechnology company specializing in therapeutic target and drug discovery for cardiovascular and cardiometabolic diseases. Their business model focuses on developing…
TL;DR
Founded: 2016
Headquarters: Germany
Focus: Human cardiac organoids, cardiotoxicity screening, and RNA-targeted therapies
Proprietary platforms: TrueCardium®, GENIMAPS®, GENISYST®
Notable support: European innovation programme awards and JLABS residency
Company Overview
Problem Domain
Cardiovascular and cardiometabolic disease drug discovery, cardiac safety pharmacology, and disease modeling.
Founded
2016
Industry
Biotechnology
Tech Stack
Funding Track Record
14189032
Record of funding with last reported date 2021-10-06 and total amount reported in evidence.
Investor Signal
“Supported by European innovation programmes including the European Innovation Council and EASME; resident at Johnson & Johnson Innovation - JLABS.”